BXP: Gateway Leasing Progress Will Support Post AI Disruption Recovery

BXP's analyst fair value estimate has been trimmed by about $1 to $68.35 as analysts factor in higher borrowing costs, heavier capital expenditure, and the potential impact of refinancings on near term growth and leverage.

Analyst Commentary

Recent Street research on BXP shows a cluster of lower price targets and more cautious modeling, with most analysts focusing on the balance between higher funding costs, capex needs, and the company’s ability to execute on leasing and asset sales.

Bullish Takeaways

Bullish analysts highlight that BXP’s portfolio is concentrated in higher end properties across several gateway markets, which they see as supportive of valuation even as occupancy is expected to sit slightly below some New York focused peers.
Some bullish analysts point to development properties and asset level monetization efforts as important levers that can contribute to value creation and support their higher price targets, including one increase to US$81.
Commentary notes improving life sciences demand in Boston and Cambridge and AI driven leasing activity, which supportive analysts see as potential helps for occupancy as it trends toward 91% in selected views.
Despite tweaks to models after quarterly results, certain bullish analysts maintain Overweight or equivalent ratings, signaling that they still see room for upside relative to their assessed fundamentals and execution track record.

Bearish Takeaways

Bearish analysts are trimming price targets into a US$60 to mid US$60s range, reflecting more conservative assumptions around interest rates, capital expenditures, and refinancing, which they see as headwinds for valuation.
Higher assumed borrowing costs and heavier near term capex are being factored into FFO estimates, with some analysts explicitly reducing out year projections to reflect these inputs.
Dilutive refinancing activity is a key concern, with cautious analysts questioning how easily BXP can reduce leverage while still funding growth projects and maintaining its asset base.
Some research flags slower than expected “flight to quality” office demand, which could limit the pace of leasing gains and keep execution risk elevated despite ongoing progress on leasing and asset sales.

What's in the News

BXP issued updated full year 2026 earnings guidance, with expected EPS of $2.15 to $2.29 per diluted share, and stated that the midpoint of guidance moved higher by $0.04 per diluted share, citing gains on sales from disposition activity and portfolio performance as key drivers (Corporate Guidance).
The company provided new earnings guidance for the second quarter of 2026, indicating expected EPS of $0.44 to $0.46 per diluted share (Corporate Guidance).
BXP announced more than 200,000 square feet of new leases at 680 Folsom and 50 Hawthorne in San Francisco, bringing 50 Hawthorne to full occupancy and 680 Folsom to more than 90% leased, including a full building lease by Dropbox and several large leases by Decagon, Swinerton Builders, and a software company (Client Announcements).
At 360 Park Avenue South in New York, BXP reported a series of long term leases totaling approximately 230,000 square feet with a weighted average lease term of 11.4 years, bringing the building to more than 90% leased across clients in financial services, hospitality, media, and technology, including an expansion by Optiver to about 115,000 square feet (Client Announcements).
BXP filed a follow on equity offering of $1b in common stock via an at the market program and subsequently withdrew a separate $600 million follow on equity offering of common stock that was also structured as an at the market program (Follow on Equity Offerings).

Valuation Changes

Fair Value: trimmed slightly from $69.30 to $68.35, a reduction of about 1.4%.
Discount Rate: risen slightly from 8.71% to 8.78%, reflecting a modestly higher required return in the model.
Revenue Growth: lowered from 5.42% to 4.90%, pointing to more cautious top line assumptions.
Net Profit Margin: adjusted down from 9.67% to 9.56%, a small reduction in modeled profitability.
Future P/E: increased from 39.6x to 40.9x, indicating a slightly higher earnings multiple embedded in the updated valuation.

0 views

Key Takeaways

Flight to quality and tenant demand for premier, well-located assets position BXP for higher rent growth, occupancy, and long-term revenue stability.
Capital recycling, focus on sustainable developments, and exposure to fast-growing innovation hubs bolster margins, cash flow resilience, and overall earnings growth.
Declining occupancy, sluggish leasing, exposure to sector and regulatory headwinds, and heightened capital risk threaten BXP's revenue growth, margins, and long-term earnings stability.

Catalysts

About BXP

BXP, Inc. (NYSE: BXP) is the largest publicly traded developer, owner, and manager of premier workplaces in the United States, concentrated in six dynamic gateway markets - Boston, Los Angeles, New York, San Francisco, Seattle, and Washington, DC.What are the underlying business or industry changes driving this perspective?

Occupancy and rent growth for BXP's high-quality, centrally located assets and premier developments are set to benefit from a marked return to in-person work mandates and a strong "flight to quality," as demonstrated by significant tenant demand, tightening vacancies (notably in NYC and Boston), and double-digit increases in asking rents in premier submarkets-supporting higher future revenues and NOI per square foot.
Rising demand driven by the expansion of knowledge-based industries-especially AI and technology in San Francisco and life sciences in Boston and Princeton-positions BXP's portfolio in innovation hubs for sustained leasing velocity, premium rents, and long-term cash flow stability, positively impacting revenue and earnings growth.
BXP's aggressive capital recycling and asset sales strategy (targeting $600 million in non-core dispositions), along with redevelopment and adaptive reuse of assets for mixed-use and multifamily, is expected to unlock higher-yielding income streams, fortify net margins, and provide non-dilutive funding for growth, supporting future FFO and earnings resilience.
The company's investment in highly amenitized, sustainable, and green-certified developments (e.g., 343 Madison), supported by strong pre-leasing to blue-chip, investment-grade tenants, directly benefits from tenant ESG priorities, enabling BXP to achieve outsized rent growth and robust development yields, thereby enhancing long-term revenue and net margin profiles.
With overall new office construction at a virtual standstill and obsolescence of commodity assets underway, BXP's well-located, modern properties in supply-constrained markets are positioned for expanding market share, higher occupancy, and greater pricing power-fueling increasingly favorable net operating income and supporting positive earnings trajectory.

BXP Future Earnings and Revenue Growth

Assumptions

How have these above catalysts been quantified?

Analysts are assuming BXP's revenue will grow by 4.9% annually over the next 3 years.
Analysts assume that profit margins will shrink from 10.0% today to 9.6% in 3 years time.
Analysts expect earnings to reach $348.4 million (and earnings per share of $2.11) by about June 2029, up from $317.2 million today. However, there is a considerable amount of disagreement amongst the analysts with the most bullish expecting $421.8 million in earnings, and the most bearish expecting $278.8 million.
In order for the above numbers to justify the price target of the analysts, the company would need to trade at a PE ratio of 41.1x on those 2029 earnings, up from 30.2x today. This future PE is greater than the current PE for the US Office REITs industry at 29.0x.
Analysts expect the number of shares outstanding to grow by 0.7% per year for the next 3 years.
To value all of this in today's terms, we will use a discount rate of 8.78%, as per the Simply Wall St company report.

Risks

What could happen that would invalidate this narrative?

BXP's occupancy declined in the quarter and management disclosed that adding newly delivered developments to the in-service portfolio will result in lower headline occupancy in the near term; persistent challenges in leasing up new projects or backfilling large tenant move-outs could suppress portfolio-wide occupancy and pressure revenue growth and NOI expansion going forward.
There are signs of stagnation or decline in rent mark-to-market spreads in key markets, with management noting reductions in rental rates for certain West Coast assets and granular rather than broad-based tenant demand, indicating that competitive pricing, higher concessions, or limited rent growth could constrain long-term top-line revenue improvements and compress net margins.
Life science leasing "continues to be light" and large established technology companies-formerly major growth drivers in gateway markets such as San Francisco-are largely absent from near-term space expansion, raising the risk that sustained sector-specific slowdowns could impair asset utilization, delay stabilization of life sciences properties, and result in weaker-than-expected earnings.
BXP's commitment to vertically developing the $2B 343 Madison project (including buying out its JV partner and assuming more funding responsibility) introduces significant capital allocation risk and future leverage pressure, which, if not managed via timely asset sales or successful recapitalization, could result in higher interest expense, lower credit rating room, or increased risk to the dividend-adversely impacting FFO and free cash flow.
The company's concentration in premier office and life sciences assets in gateway cities leaves it exposed to macro and regulatory headwinds-such as potential adverse political shifts (e.g., New York City's mayoral race), ongoing remote/hybrid work trends, or higher capital expenditure requirements for sustainability upgrades-that could raise long-term operating costs or depress effective demand, reducing net margins and overall earnings resiliency.

Valuation

How have all the factors above been brought together to estimate a fair value?

The analysts have a consensus price target of $68.35 for BXP based on their expectations of its future earnings growth, profit margins and other risk factors.
However, there is a degree of disagreement amongst analysts, with the most bullish reporting a price target of $89.0, and the most bearish reporting a price target of just $58.0.
In order for you to agree with the analysts, you'd need to believe that by 2029, revenues will be $3.6 billion, earnings will come to $348.4 million, and it would be trading on a PE ratio of 41.1x, assuming you use a discount rate of 8.8%.
Given the current share price of $60.01, the analyst price target of $68.35 is 12.2% higher.
We always encourage you to reach your own conclusions though. So sense check these analyst numbers against your own assumptions and expectations based on your understanding of the business and what you believe is probable.

Have other thoughts on BXP?

Create your own narrative on this stock, and estimate its Fair Value using our Valuator tool.

Create Narrative

How well do narratives help inform your perspective?

Disclaimer

AnalystConsensusTarget is a tool utilizing a Large Language Model (LLM) that ingests data on consensus price targets, forecasted revenue and earnings figures, as well as the transcripts of earnings calls to produce qualitative analysis. The narratives produced by AnalystConsensusTarget are general in nature and are based solely on analyst data and publicly-available material published by the respective companies. These scenarios are not indicative of the company's future performance and are exploratory in nature. Simply Wall St has no position in the company(s) mentioned. Simply Wall St may provide the securities issuer or related entities with website advertising services for a fee, on an arm's length basis. These relationships have no impact on the way we conduct our business, the content we host, or how our content is served to users. The price targets and estimates used are consensus data, and do not constitute a recommendation to buy or sell any stock, and they do not take account of your objectives, or your financial situation. Note that AnalystConsensusTarget's analysis may not factor in the latest price-sensitive company announcements or qualitative material.

Gateway Office Demand And Disposition Plans Will Shape Performance Ahead